Delivery Order SPE2DB22D9207-SPE2DB25FH4YB

Award Date 3/26/25
Potential Completion Date 4/16/25
Potential Value $7.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the delivery of 4,562,293,327 units of Mirena 52 mg systems. The award, valued at $29,048.00, has an ultimate completion date of October 11, 2023. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,564,414,792 units of the Mirena 52 mg intrauterine contraceptive system. The contract has a ceiling value of $11,840.00 and an ultimate completion date of May 15, 2024. This delivery order was issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (SPE2DB) with the DLA's Medical Supply Chain...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $12,432.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg systems, a type of contraceptive implant. This delivery order is part of a larger indefinite delivery, indefinite quantity (IDIQ) contract, number SPE2DB24FY22J, held by DMS Pharmaceutical Group with DLA. The IDIQ contract, valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth up to $1,184.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,564,029,380 units of Mirena 52 mg contraceptive intrauterine systems. The delivery order has an ultimate completion date of April 8, 2024 and was awarded on March 18, 2024. This contract is part of DMS Pharmaceutical Group's existing indefinite delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,184.00 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of MIRENA 52 MG SYSTEMS. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through the end of 2025. Through this IDV, DLA can issue firm-fixed-price delivery orders for a broad range of pharmaceutical items to...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $13,024.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg intrauterine systems, a contraceptive product. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDV) SPE2DB with DLA, valued at up to $4,999,999 through 2025, which...
The Defense Logistics Agency (DLA) awarded a $8,288 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of Mirena 52 mg intrauterine contraceptive systems. This order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, contract SPE2DB22D9130, valued up to $4,999,999 through 2025. The contract has no set-aside designation. Under this delivery order, DMS Pharmaceutical Group will provide...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,840.00, is for the supply of Mirena 52 mg systems, a contraceptive device. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to place...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,960.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Mirena 52 mg systems, a type of contraceptive device, to support the medical supply needs of military healthcare facilities. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA...
The Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Mirena 52 mg systems. The contract, valued at $11,840.00, has an ultimate completion date of September 24, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc. under the SPE2DB program, valued at up to $499,999,999, which runs through...
  • SPE2DB22D9207
    Indefinite Delivery Contract
  • SPE2DB22D9207-SPE2DB25FH4YB
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $7,811.55 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the procurement of 4,567,759,894 units of the Mirena 52 mg contraceptive system. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a wide range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The contract has an ultimate completion date of April 16, 2025 and does not have a set-aside designation.

Generated 6/29/25, 1:23 AM